JPH0231687B2 - - Google Patents
Info
- Publication number
- JPH0231687B2 JPH0231687B2 JP57101872A JP10187282A JPH0231687B2 JP H0231687 B2 JPH0231687 B2 JP H0231687B2 JP 57101872 A JP57101872 A JP 57101872A JP 10187282 A JP10187282 A JP 10187282A JP H0231687 B2 JPH0231687 B2 JP H0231687B2
- Authority
- JP
- Japan
- Prior art keywords
- stevioside
- skin
- present
- weight
- emulsion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 30
- 229940013618 stevioside Drugs 0.000 claims description 29
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 29
- 235000019202 steviosides Nutrition 0.000 claims description 29
- 239000002537 cosmetic Substances 0.000 claims description 13
- 239000000126 substance Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000004945 emulsification Methods 0.000 claims description 5
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 229920003169 water-soluble polymer Polymers 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 description 19
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 11
- 239000006071 cream Substances 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 239000004094 surface-active agent Substances 0.000 description 10
- 206010015150 Erythema Diseases 0.000 description 9
- 231100000321 erythema Toxicity 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 7
- 230000001804 emulsifying effect Effects 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 229960000541 cetyl alcohol Drugs 0.000 description 6
- 230000007794 irritation Effects 0.000 description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 6
- 229920001285 xanthan gum Polymers 0.000 description 6
- 239000000230 xanthan gum Substances 0.000 description 6
- 235000010493 xanthan gum Nutrition 0.000 description 6
- 229940082509 xanthan gum Drugs 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 229940057995 liquid paraffin Drugs 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 3
- 235000011613 Pinus brutia Nutrition 0.000 description 3
- 241000018646 Pinus brutia Species 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 3
- 229960002216 methylparaben Drugs 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000002884 skin cream Substances 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229940073665 octyldodecyl myristate Drugs 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 208000019300 CLIPPERS Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000287227 Fringillidae Species 0.000 description 1
- CGBXSWXZXBQCMR-UHFFFAOYSA-N Glycerol 1-hexadecanoate Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCC(O)=O CGBXSWXZXBQCMR-UHFFFAOYSA-N 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- HIWPGCMGAMJNRG-ACCAVRKYSA-N Sophorose Natural products O([C@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HIWPGCMGAMJNRG-ACCAVRKYSA-N 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- QFVOYBUQQBFCRH-UHFFFAOYSA-N Steviol Natural products C1CC2(C3)CC(=C)C3(O)CCC2C2(C)C1C(C)(C(O)=O)CCC2 QFVOYBUQQBFCRH-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960002246 beta-d-glucopyranose Drugs 0.000 description 1
- HIWPGCMGAMJNRG-BTLHAWITSA-N beta-sophorose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HIWPGCMGAMJNRG-BTLHAWITSA-N 0.000 description 1
- HIWPGCMGAMJNRG-UHFFFAOYSA-N beta-sophorose Natural products OC1C(O)C(CO)OC(O)C1OC1C(O)C(O)C(O)C(CO)O1 HIWPGCMGAMJNRG-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 231100000299 mutagenicity Toxicity 0.000 description 1
- 230000007886 mutagenicity Effects 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- -1 natural surfactant) Chemical class 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical group O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- HIWPGCMGAMJNRG-RTPHMHGBSA-N sophorose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HIWPGCMGAMJNRG-RTPHMHGBSA-N 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- QFVOYBUQQBFCRH-VQSWZGCSSA-N steviol Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)CC1)C[C@H]2[C@@]2(C)[C@H]1[C@](C)(C(O)=O)CCC2 QFVOYBUQQBFCRH-VQSWZGCSSA-N 0.000 description 1
- 229940032084 steviol Drugs 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 231100000456 subacute toxicity Toxicity 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Description
本発明は、主体構成成分として油性物質、水、
乳化剤、水溶性高分子および乳化助剤としてステ
ビオシドを配合してなる皮膚用または毛髪用乳化
化粧料である。ステビオシド(Stevioside)は、
南米パラグアイに自生する菊科の多年生薬用植物
ステビア・レバウジアナ・ベルトニー(Stevia
Rebaudiana Bertoni)の葉から抽出されるシヨ
糖の約300倍の甘味を有する物質であり、高血圧、
糖尿病患者の薬用甘味剤としても用いられてい
る。その構造は、ステビオールと名づけられたジ
テルペンとソホロース(2−O−β−D−グルコ
ピラノシル−β−D−グルコピラノース)および
β−D−グルコピラノースからなるジテルペン配
糖体(A)である。
ステビオシドの構造式
従来、乳化剤や可溶化剤として使用される合成
界面活性剤は皮膚に対しての刺激等の問題があ
り、安全性の高い物質やその誘導体の界面活性物
質に置換える試みがなされている。
本発明において、上記ステビオシドが、クリー
ム、乳液等の皮膚用または毛髪用乳化化粧料にお
けるあるいは乳化助剤として極めて有効であるこ
とを見出した。すなわち、ステビオシドのみの乳
化力は非常に弱いが、界面活性剤であるグリセリ
ンモノ脂肪酸エステルと併用するとその乳化力が
著しく向上することを見出し、本発明に至つた。
又、油性物質が多い場合には、さらに水溶性高分
子(特に天然系界面活性物質)であり増粘効果も
有するキサンタンガム等を加えると乳化安定性の
高い化粧料となる。又、グリチルリチン酸誘導体
の場合のように、ペクチン等の水溶性多糖類を併
用すると、乳化安定性は良くなるが、起泡性も高
まり製造時(乳化時)の脱泡が問題となり大量生
産への移行はかなり困難であるが、本発明におけ
るステビオシドを用いた場合、このような起泡性
が生じないのも、一つの特徴であり、製造時の脱
泡あるいは大量生産への移行には、何ら問題が生
じないのも大きな特徴である。
本発明の目的は、皮膚に対して安全性が高く、
乳化安定性および保存安定性に優れ、かつ使用感
の良好な乳化化粧料を提供することにある。また
本発明の他の目的は、新規な乳化剤の組成を提供
することにある。
すなわち、本発明は、主体構成成分としてステ
ビオシド、グリセリンモノ脂肪酸エステル、水溶
性高分子(特に天然系界面活性物質)、油性物質
および水を配合してなる皮膚用または毛髪用乳化
化粧料である。
本発明に使用するステビオシドは、通常市販さ
れているもので良く、又、乳酸、デキストリン等
で増量したステビオシドを使用しても良い。ステ
ビオシドの使用量としては、通常0.01〜5.0重量
%、好ましくは0.02〜2.0重量%である。0.01重量
%より少ないと、乳化安定性が悪く、ステビオシ
ド添加による効果がほとんど得られない為、本発
明においては不適である。また5.0重量%以上の
配合も可能であるが、乳化系によつては、かえつ
て乳化粒子が大きくなり、ゲル化の傾向が見られ
ることから、本発明においては好ましくない。
本発明に使用するグリセリンモノ脂肪酸エステ
ルとしては、グリセリンモノステアレート、グリ
セリンモノパルミテート等があげられる。その使
用量は0.1〜10.0重量%、好ましくは0.5〜5.0重量
%である。0.1重量%以下においては、乳化安定
性が悪く、又、10重量%以上においては、乳化系
が経時的に堅くなる為、本発明では不適である。
本発明においては、ステビオシドの効果を顕著に
みるため、乳化力の比較的弱く皮膚刺激等に対し
て安全性の高いグリセリンモノ脂肪酸エステルと
ステビオシドとの併用を例に検討したが、既存の
乳化力の強い合成あるいは天然の界面活性剤との
併用あるいは置換えも十分可能である。
本発明に使用する油性物質としては、公知の皮
膚化粧料用油性物質であれば、どんなものでもよ
く、スクワラン、流動パラフイン等炭化水素、セ
チルアルコール、ステアリルアルコール等の高級
アルコール、ステアリン酸、ベヘニン酸等の高級
脂肪酸、オクチルドデシルミリステート等のエス
テル油の他、動植物油脂類、ロウ類、シリコン油
等が挙げられる。これらの油性物質は、単独又は
2種以上の組合せで使用され、その使用量は10〜
80重量%、好ましくは20〜70重量%である。10重
量%以下では乳化安定性が悪く、80重量%以上で
はベタツキが著しく、本発明においては不適であ
る。
次に、水の使用量は10〜90重量%、好ましくは
20〜80重量%である。
本発明の使用し得るステビオシドは、PHの条件
等に関係なく良好な界面活性能を示すが、油性物
質の配合量の多い場合は、キサンタンガム、ロー
カストビンガム、カラギーナン、レシチン、シヨ
糖脂肪酸エステル等の天然系界面活性物質やベン
トナイトを配合すると、油性物質を極めて安定に
乳化することができる。これらは、1種又は2種
以上の組合せで使用することができ、その配合量
は0.01〜8.0重量%、好ましくは0.1〜3.0重量%で
ある。
更に、必要に応じて美容薬効成分、保湿剤、防
腐剤、香料、着色料、顔料等を加えることも可能
である。
本発明の乳化化粧料は水とステビオシドを加熱
撹拌して溶解した後、加熱溶融した油性物質中
に、撹拌下に添加、混合して乳化する等の公知の
製造方法によつて製造される。
本発明の皮膚用または毛髪用乳化化粧料として
は、例えば、スキンクリーム、マツサージクリー
ム、クレンジングクリーム、乳液、フアンデーシ
ヨンクリーム、ヘアークリーム、ボデイクリーム
等の皮膚、毛髪、全身用乳化化粧料に適用され
る。
又、ステビオシドは、乳化力を備えた甘味剤と
も考えられることから、食品等への応用も十分期
待できる。
本発明の乳化化粧料は、皮膚に対しての安全性
が高く、使用感および外観も良好であり、しかも
乳化安定性および経時安定性が優れており、極め
て製品価値の高いものである。
以下実施例を挙げて説明する。実施例に示す配
合量の部とは重量部を示す。
実施例 1
乳 液
A 処方 配合量
1 スクワラン 20.0部
2 ミリスチン酸オクチルドデシル 1.5
3 セチルアルコール 2.0
4 グリセリンモノステアレート 2.0
5 ステビオシド 0.5
6 キサンタンガム 0.3
7 メチルパラベン 0.1
8 精製水 33.5
9 香料 0.1
B 製造法;油成成分〜および水溶性成分
〜をそれぞれ75〜80℃に加熱して均一に溶解
する。次に油成成分をホモミキサーを用いて撹
拌しながら、水溶性成分を加えて乳化した後冷
却する。冷却途上、60℃にて成分を加えて混
合し、30℃まで冷却し製品を得る。得られた乳
液はo/w型のエマルジヨンで、使用感および
肌目、光沢等の外観も良く、5〜40℃の恒温槽
内で3カ月後も極めて安定であり、流動性にも
優れていた。
実施例 2
本発明の効果をみるため、実施例1と同様にし
て、各乳液を製造した。それらの処方を表1に、
又、結果を表2にまとめて示した。尚、処方1、
2、3は比較例である。
The present invention uses an oily substance, water, and
This is an emulsified cosmetic for skin or hair that contains an emulsifier, a water-soluble polymer, and stevioside as an emulsification aid. Stevioside is
Stevia rebaugiana bertoni is a perennial medicinal plant of the Chrysanthemum family that grows wild in Paraguay, South America.
Rebaudiana Bertoni) is a substance that is approximately 300 times sweeter than sucrose extracted from the leaves of Rebaudiana Bertoni.
It is also used as a medicinal sweetener for diabetics. Its structure is a diterpene glycoside (A) consisting of a diterpene named steviol, sophorose (2-O-β-D-glucopyranosyl-β-D-glucopyranose) and β-D-glucopyranose. Structural formula of stevioside Synthetic surfactants conventionally used as emulsifiers and solubilizers have problems such as irritation to the skin, and attempts have been made to replace them with surfactant substances that are highly safe or their derivatives. In the present invention, it has been found that the above-mentioned stevioside is extremely effective in emulsified cosmetics for the skin or hair such as creams and emulsions, or as an emulsification aid. That is, the emulsifying power of stevioside alone is very weak, but when used in combination with glycerin monofatty acid ester, which is a surfactant, the emulsifying power is significantly improved, leading to the present invention.
If there is a large amount of oily substances, adding xanthan gum, which is a water-soluble polymer (particularly a natural surfactant) and has a thickening effect, will result in a cosmetic with high emulsion stability. In addition, as in the case of glycyrrhizic acid derivatives, when water-soluble polysaccharides such as pectin are used in combination, emulsion stability improves, but foaming properties also increase and defoaming during manufacturing (emulsification) becomes a problem, leading to mass production. However, when using stevioside in the present invention, one of the characteristics is that such foaming does not occur. Another major feature is that it does not cause any problems. The purpose of the present invention is to have high safety for the skin;
An object of the present invention is to provide an emulsified cosmetic that has excellent emulsion stability and storage stability, and has a good feel when used. Another object of the present invention is to provide a novel emulsifier composition. That is, the present invention is an emulsified cosmetic for skin or hair that contains stevioside, glycerin monofatty acid ester, water-soluble polymer (particularly natural surfactant), oily substance, and water as main components. The stevioside used in the present invention may be a commercially available one, or stevioside increased in volume with lactic acid, dextrin, etc. may be used. The amount of stevioside used is usually 0.01 to 5.0% by weight, preferably 0.02 to 2.0% by weight. If it is less than 0.01% by weight, the emulsion stability will be poor and the effect of adding stevioside will hardly be obtained, so it is not suitable for the present invention. It is also possible to incorporate 5.0% by weight or more, but this is not preferred in the present invention because depending on the emulsifying system, the emulsified particles may become larger and tend to gel. Examples of the glycerin monofatty acid ester used in the present invention include glycerin monostearate and glycerin monopalmitate. The amount used is 0.1-10.0% by weight, preferably 0.5-5.0% by weight. If it is less than 0.1% by weight, the emulsion stability will be poor, and if it is more than 10% by weight, the emulsion system will become hard over time, which is not suitable for the present invention.
In the present invention, in order to clearly see the effect of stevioside, we investigated the use of stevioside in combination with glycerin monofatty acid ester, which has a relatively weak emulsifying power and is highly safe against skin irritation, etc., but the existing emulsifying power It is also possible to combine or replace strong synthetic or natural surfactants. The oily substance used in the present invention may be any known oily substance for skin cosmetics, including hydrocarbons such as squalane and liquid paraffin, higher alcohols such as cetyl alcohol and stearyl alcohol, stearic acid, and behenic acid. In addition to higher fatty acids such as ester oils such as octyldodecyl myristate, animal and vegetable fats and oils, waxes, silicone oils, and the like. These oily substances are used alone or in combination of two or more, and the amount used is 10~
80% by weight, preferably 20-70% by weight. If it is less than 10% by weight, the emulsion stability will be poor, and if it is more than 80% by weight, it will become extremely sticky, which is not suitable for the present invention. Then the amount of water used is 10-90% by weight, preferably
20-80% by weight. Stevioside that can be used in the present invention exhibits good surfactant ability regardless of PH conditions, etc., but when a large amount of oily substances is blended, By blending natural surfactants and bentonite, oily substances can be emulsified extremely stably. These can be used alone or in combination of two or more, and the blending amount is 0.01 to 8.0% by weight, preferably 0.1 to 3.0% by weight. Furthermore, it is also possible to add cosmetic medicinal ingredients, humectants, preservatives, fragrances, colorants, pigments, etc., as necessary. The emulsified cosmetic composition of the present invention is produced by a known production method, such as dissolving water and stevioside by heating and stirring, and then adding the mixture to a heated and molten oily substance, mixing and emulsifying with stirring. The emulsified cosmetics for skin or hair of the present invention are applicable to skin, hair, and whole body emulsified cosmetics such as skin creams, pine surge creams, cleansing creams, milky lotions, foundation creams, hair creams, and body creams. be done. Furthermore, since stevioside is considered to be a sweetener with emulsifying power, it can be fully expected to be applied to foods and the like. The emulsified cosmetic composition of the present invention is highly safe for the skin, has good feel and appearance, and has excellent emulsion stability and stability over time, and has extremely high product value. This will be explained below with reference to examples. The amounts shown in Examples are parts by weight. Example 1 Emulsion A Formula Amount 1 Squalane 20.0 parts 2 Octyldodecyl myristate 1.5 3 Cetyl alcohol 2.0 4 Glycerin monostearate 2.0 5 Stevioside 0.5 6 Xanthan gum 0.3 7 Methylparaben 0.1 8 Purified water 33.5 9 Fragrance 0.1 B Manufacturing method; oil Components ~ and water-soluble components ~ are each heated to 75 to 80°C to uniformly dissolve them. Next, while stirring the oil component using a homomixer, a water-soluble component is added and emulsified, followed by cooling. During cooling, the ingredients are added and mixed at 60°C, and the product is obtained by cooling to 30°C. The obtained emulsion is an o/w type emulsion that has good texture, texture, and gloss, and is extremely stable even after 3 months in a thermostat at 5 to 40°C, and has excellent fluidity. Ta. Example 2 In order to examine the effects of the present invention, various emulsions were produced in the same manner as in Example 1. Their prescriptions are shown in Table 1.
Further, the results are summarized in Table 2. In addition, prescription 1,
2 and 3 are comparative examples.
【表】【table】
【表】【table】
【表】
表2からも明らかなように、ステビオシド添加
の効果が顕著に現われている。グリセリンモノス
テアレートあるいはステビオシドを処方から抜く
とほとんど乳化しない。グリセリンモノステアレ
ートとステビオシドを併用すると乳化状態が良く
なり、さらに天然の界面活性物質であるキサンタ
ンガムを添加すると経時安定性が増加する。又、
界面活性力のあるセタノール(試料7)、ステア
リン酸、レシチン、コレステロール等をさらに添
加すると経時安定性の良い、肌目の極めて良好な
乳液となる。一方、ステビオシドの使用量が、
0.01重量%以下においては経時安定性に欠ける
が、それ以上の使用量においては、乳化粒子を均
一かつ細かくし、乳化安定性の良い乳液となる。
ステビオシドの使用量が2.0重量%以上になると、
ややゲルつぽくなり、乳化粒子も逆に大きくなる
ため、使用感が悪くなる傾向がみられる。
実施例 3
マツサージクリーム
A 処方
1 流動パラフイン 50.0部
2 セチルアルコール 2.0
3 グリセリンモノステアレート 2.0
4 コレステロール 0.5
5 ステビオシド 0.5
6 キサンタンガム 0.3
7 メチルパラベン 0.2
8 精製水 33.0
9 香料 適量
B 製造法;実施例1に準じて行なつた。得られ
たマツサージクリームは、O/W型のエマルジ
ヨンであり、肌目、光沢等の外観が良く、5〜
40℃恒温槽内で、3ケ月保存後も極めて安定で
あつた。
実施例 4
スキンクリーム
A 処方
1 流動パラフイン 20.0部
2 スクワラン 5.0
3 ミリスチン酸オクチルドデシル 5.0
4 グリセリンモノステアレート 2.5
5 セチルアルコール 2.0
6 ステビオシド 0.8
7 キサンタンガム 0.3
8 1,3ブチレングリコール 5.0
9 メチルパラベン 0.2
10 精製水 59.1
11 香料 0.1
B 製造法;実施例1に準じて行なつた。得られ
たスキンクリームはO/W型のエマルジヨン
で、使用感および外観も良く、5〜40℃恒温槽
内で3ケ月後も安定であつた。
実施例 5
フアンデーシヨンクリーム
1 スクワラン 5.0部
2 流動パラフイン 15.0
3 グリセリンモノステアレート 2.5
4 セチルアルコール 1.0
5 ブチルパラベン 0.2
6 ステビオシド 0.5
7 キサンタンガム 0.3
8 ベントナイト 0.5
9 顔料 6.0
10 精製水 68.9
11 香料 0.1
B 製造法;顔料を水相に分散させた後、実施例
1に準じて行なつた。得られたフアンデーシヨ
ンクリームはO/W型エマルジヨンで、外観、
使用感いずれも良好であり、5〜40℃恒温槽で
3ケ月後も安定であり、顔料の凝集固化等はお
こらなかつた。
本発明に用いたステビオシドは、わが国で行な
われた安全性試験(急性毒性・変異原性・妊娠抑
制・亜急性毒性)によつて極めて安全性の高いも
のと評価されているものである。
本発明化粧料の安全性をさらに明らかにするた
めに、下記の刺激試験を行なつた。
動物試験(Draize法による)
試験法;体重2.5〜3.0Kgの日本白色種家兎をバ
リカンにて背部の毛を刈り、5羽の正常皮膚
の家兎を用いて固定台に固定する。被検試料
(実施例1の試料)の適量を2×2cmのリン
ト布の絆創膏上につけて皮膚に貼布し、24時
間後にリント布を取り除き皮膚の反応を判定
基準に従つて、紅斑と浮腫について観察す
る。72時間後に再び判定を行ない、24時間と
72時間の平均をとつて判定した。
判定;
(1) 紅斑および病皮の形成 判定数値
●紅斑のまつたく認められないもの 0
●わずかな紅斑が認められるもの 1
●明らかな紅斑が認められるもの 2
●強い紅斑が認められるもの 3
●強い紅斑にわずかな痂皮の認められるも
の 4
(2) 浮腫の形成 判定数値
●浮腫の認められないもの 0
●非常にわずかな浮腫が認められるもの
1
●わずかな浮腫が認められるもの 2
●中程度(約1mm程度)の浮腫が認められ
るもの 3
●強い浮腫(貼布範囲外にはみ出す)が認
められるもの 4
被検物質の評価:判定数値の平均和
2以下…わずかな刺激性又はほとんど刺激性
なし
2.1〜5.0…中程度の刺激性あり
5以上…強い刺激性あり
人体試験(人体閉鎖パツチテストによる)
試験法:フインチヤンバー(大正製薬)を用い
前腕屈側部に48時間の閉鎖貼布を行なう。判
定は48時間後および72時間後に行なう。ただ
し、反応が強く貼布部位に掻痒疼等がある場
合には、貼布を中止する。
実施人員:健康人50名
判定基準:全く変化なし(−)
かすかな紅斑(±)
明らかな紅斑(+)
実施例1に示したステビオシド組成物を被検
試料とした。
以上の試験結果は、動物皮膚刺激スコアーは0
であり、人体皮膚刺激試験の結果は全員(−)で
あり、本発明の前記各ステビオシド組成物は、安
全性の高いものであることが確認された。[Table] As is clear from Table 2, the effect of the addition of stevioside is remarkable. If glycerin monostearate or stevioside is omitted from the formulation, it will hardly emulsify. The combined use of glycerin monostearate and stevioside improves the emulsification state, and addition of xanthan gum, a natural surfactant, increases stability over time. or,
When cetanol (sample 7), which has surfactant properties, stearic acid, lecithin, cholesterol, etc. are further added, a milky lotion with good stability over time and an extremely good texture can be obtained. On the other hand, the amount of stevioside used is
If the amount is less than 0.01% by weight, the stability over time will be poor, but if the amount is more than 0.01% by weight, the emulsion particles will be made uniform and fine, resulting in an emulsion with good emulsion stability.
When the amount of stevioside used is 2.0% by weight or more,
It becomes a little gel-like and the emulsified particles also become larger, so there is a tendency for the feeling of use to be poor. Example 3 Pine surge cream A Formulation 1 Liquid paraffin 50.0 parts 2 Cetyl alcohol 2.0 3 Glycerin monostearate 2.0 4 Cholesterol 0.5 5 Stevioside 0.5 6 Xanthan gum 0.3 7 Methylparaben 0.2 8 Purified water 33.0 9 Fragrance Appropriate amount B Manufacturing method; Same as Example 1 I did it. The obtained pine surge cream is an O/W type emulsion, has good appearance such as texture and gloss, and has a rating of 5~
It remained extremely stable even after being stored for 3 months in a 40°C constant temperature bath. Example 4 Skin cream A Formulation 1 Liquid paraffin 20.0 parts 2 Squalane 5.0 3 Octyldodecyl myristate 5.0 4 Glycerin monostearate 2.5 5 Cetyl alcohol 2.0 6 Stevioside 0.8 7 Xanthan gum 0.3 8 1,3-butylene glycol 5.0 9 Methylparaben 0.2 10 Purified water 59.1 11 Perfumery 0.1 B Manufacturing method: Produced according to Example 1. The obtained skin cream was an O/W type emulsion, had good feel and appearance, and remained stable even after 3 months in a thermostat at 5 to 40°C. Example 5 Foundation cream 1 Squalane 5.0 parts 2 Liquid paraffin 15.0 3 Glycerin monostearate 2.5 4 Cetyl alcohol 1.0 5 Butylparaben 0.2 6 Stevioside 0.5 7 Xanthan gum 0.3 8 Bentonite 0.5 9 Pigment 6.0 10 Purified water 68.9 11 Fragrance 0. 1B Manufacturing Method: After dispersing the pigment in an aqueous phase, the same procedure as in Example 1 was followed. The obtained foundation cream is an O/W emulsion with an appearance,
The feeling of use was good, and it was stable even after 3 months in a constant temperature bath of 5 to 40°C, and no agglomeration or solidification of the pigment occurred. Stevioside used in the present invention has been evaluated to be extremely safe in safety tests (acute toxicity, mutagenicity, pregnancy suppression, subacute toxicity) conducted in Japan. In order to further clarify the safety of the cosmetic composition of the present invention, the following irritation test was conducted. Animal test (by Draize method) Test method: The hair on the back of Japanese white rabbits weighing 2.5 to 3.0 kg is clipped with clippers, and 5 rabbits with normal skin are fixed on a fixing table. Apply an appropriate amount of the test sample (sample of Example 1) to a 2 x 2 cm lint cloth adhesive plaster and apply it to the skin. After 24 hours, remove the lint cloth and check the skin reaction according to the criteria to determine erythema and edema. Observe about. Judgment will be made again after 72 hours, and 24 hours will be determined.
Judgment was made by taking the average over 72 hours. Judgment: (1) Formation of erythema and diseased skin Judgment values ●No noticeable erythema 0 ●Slight erythema 1 ●Clear erythema 2 ●Strong erythema 3 ● Strong erythema with a slight crust 4 (2) Formation of edema Judgment value●No edema observed 0●Very slight edema observed
1 ●Those with slight edema 2 ●Those with moderate edema (approximately 1 mm) 3 ●Those with strong edema (protruding outside the patch area) 4 Evaluation of test substance: Judgment numerical value Average sum 2 or less...Slight irritation or almost no irritation 2.1-5.0...Moderate irritation 5 or more...Strong irritation Human test (by human body closed patch test) Test method: Finch Yanbar (Taisho Pharmaceutical) A 48-hour occlusive patch is applied to the flexor side of the forearm. Judgments are made after 48 hours and 72 hours. However, if there is a strong reaction and itching occurs at the application site, discontinue application. Participants: 50 healthy people Judgment criteria: No change at all (-) Faint erythema (±) Obvious erythema (+) The stevioside composition shown in Example 1 was used as a test sample. The above test results indicate that the animal skin irritation score is 0.
The results of the human skin irritation test were all negative (-), confirming that each of the stevioside compositions of the present invention is highly safe.
Claims (1)
乳化助剤としてステビオシドを配合してなる皮膚
用または毛髪用乳化化粧料。1. An emulsified cosmetic for skin or hair containing an oily substance, water, an emulsifier, a water-soluble polymer, and stevioside as an emulsification aid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10187282A JPS58219105A (en) | 1982-06-14 | 1982-06-14 | Emulsified cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10187282A JPS58219105A (en) | 1982-06-14 | 1982-06-14 | Emulsified cosmetic |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS58219105A JPS58219105A (en) | 1983-12-20 |
JPH0231687B2 true JPH0231687B2 (en) | 1990-07-16 |
Family
ID=14312067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10187282A Granted JPS58219105A (en) | 1982-06-14 | 1982-06-14 | Emulsified cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS58219105A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03251380A (en) * | 1990-02-27 | 1991-11-08 | Oki Electric Ind Co Ltd | Suction collet |
JPH0432889U (en) * | 1990-07-11 | 1992-03-17 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51184A (en) * | 1974-06-19 | 1976-01-05 | Shiro Okamura |
-
1982
- 1982-06-14 JP JP10187282A patent/JPS58219105A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51184A (en) * | 1974-06-19 | 1976-01-05 | Shiro Okamura |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03251380A (en) * | 1990-02-27 | 1991-11-08 | Oki Electric Ind Co Ltd | Suction collet |
JPH0432889U (en) * | 1990-07-11 | 1992-03-17 |
Also Published As
Publication number | Publication date |
---|---|
JPS58219105A (en) | 1983-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1239588A (en) | Sensitive skin care regime | |
JP2554880B2 (en) | Skin cosmetics | |
AU724527B2 (en) | Emulsifier composition for skin care formulations | |
DE69818586T2 (en) | Emulsifying composition of polyglycosides and fatty alcohol | |
JPS625881B2 (en) | ||
DE2408663A1 (en) | THIXOTROPIC EMULSIONS WITH A HIGH CONTENT IN THE INNER PHASE AND THEIR USE | |
JP2944258B2 (en) | Emulsion type cosmetic | |
WO1998013436A1 (en) | Humectant composition, base containing the same, and cosmetic material or external preparation containing said humectant composition | |
EP0375082B1 (en) | Cosmetic composition | |
KR102236418B1 (en) | Cosmetic composition containing ceramide having a refreshing sensation | |
EP0660702A1 (en) | Water-in-oil emulsions containing water-soluble alkyl glycosides | |
JPS597106A (en) | Emulsifiable composition | |
JP2001288068A (en) | Skin cosmetic | |
JPH0231687B2 (en) | ||
JP3308555B2 (en) | Method for producing finely divided emulsion composition | |
JP2022102419A (en) | Oil-in-water drop type emulsified product | |
JP3597520B2 (en) | External preparation for skin | |
JPH07304629A (en) | Water-in-oil type emulsion composition and its production | |
JPH0710338B2 (en) | Oil-in-water emulsion composition and polyhydric alcohol-in-oil emulsion composition | |
JPH0463042B2 (en) | ||
JPS624214A (en) | Cosmetic | |
JPH02169507A (en) | Cosmetic | |
JP2004123661A (en) | Skin care preparation for external use | |
JP2781626B2 (en) | Solubilized transparent cosmetic | |
JPH01100113A (en) | External preparation for skin |